<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01607489</url>
  </required_header>
  <id_info>
    <org_study_id>23-356 ex 10/11</org_study_id>
    <nct_id>NCT01607489</nct_id>
  </id_info>
  <brief_title>Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography</brief_title>
  <official_title>Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography - Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ludwig Boltzmann Gesellschaft</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine relevant hemodynamic parameters for the diagnostics of&#xD;
      pulmonary arterial hypertension (PAH) by dynamic contrast enhanced dual-energy CT (DE-CT). In&#xD;
      this pilot study the investigators investigate patients who underwent right heart&#xD;
      catheterisation with DE-CT to determine hemodynamic parameters and control the results by&#xD;
      other clinical investigations. The investigators expect that using this non-invasive method,&#xD;
      parameters relevant for the diagnosis of the patients with PAH, like pulmonary blood volume,&#xD;
      blood flow and perfusion heterogeneity, can be determined.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulmonary arterial hypertension (PAH) is a rare, life-threatening disease. It is&#xD;
      characterized by the elevation of pulmonary arterial pressure and pulmonary vascular&#xD;
      resistance. A remodeling of small pulmonary vessels characterized by the proliferation of the&#xD;
      adventitia, the hypertrophy of the media and fibrosis of the intima can be observed on the&#xD;
      microscopic level.&#xD;
&#xD;
      Non-invasive techniques for hemodynamic assessment and identification of early pulmonary&#xD;
      vascular remodeling and pulmonary hypertension have a marked practical advantage as compared&#xD;
      to invasive right heart catheterization, however, their accuracy and reliability is not well&#xD;
      established.&#xD;
&#xD;
      In the present study the investigators examine patients who underwent right heart&#xD;
      catheterization and are scheduled for a thorax CT with an additional dynamic&#xD;
      contrast-enhanced DE-CT protocol and derive established parameters for the diagnosis of PAH&#xD;
      as well as novel parameters from the CT scans. These are compared to results from the&#xD;
      right-heart catheterization and other investigations routinely carried out on these patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary blood flow and volume determined by dual energy computed tomography</measure>
    <time_frame>measurements with right heart catheterisation within 1 month</time_frame>
    <description>determination of differences in pulmonary blood flow and volume of pulmonary hypertension patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of dual energy computed tomography derived data with clinical findings of pulmonary hypertension patients</measure>
    <time_frame>measurements with right heart catheterisation within 1 month</time_frame>
    <description>comparison of different state or type of pulmonary hypertension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung perfusion heterogeneity determined by dual energy computed tomography</measure>
    <time_frame>measurements with right heart catheterisation within 1 month</time_frame>
    <description>quantification of regional perfusion differences in pulmonary hypertension patients</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>pulmonary vascular disease</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Dual-energy computed tomography investigation</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Dual-energy computed tomography investigation</intervention_name>
    <description>1x 20ml Ultravist (370mg J/ml)3-5ml/s,&#xD;
1x 70ml Ultravist (370mg J/ml)3-5ml/s Contrast agent administration</description>
    <arm_group_label>pulmonary vascular disease</arm_group_label>
    <other_name>CT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with right heart catheterization data&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with decreased renal function&#xD;
&#xD;
          -  patients who received CT in the previous six months&#xD;
&#xD;
          -  intolerance of contrast material&#xD;
&#xD;
          -  other standard CT contraindications&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horst Olschewski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Graz, Division of Pulmonology</name>
      <address>
        <city>Graz</city>
        <state>Steiermark</state>
        <zip>8010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <results_reference>
    <citation>Helmberger M, Pienn M, Urschler M, Kullnig P, Stollberger R, Kovacs G, Olschewski A, Olschewski H, Bálint Z. Quantification of tortuosity and fractal dimension of the lung vessels in pulmonary hypertension patients. PLoS One. 2014 Jan 31;9(1):e87515. doi: 10.1371/journal.pone.0087515. eCollection 2014.</citation>
    <PMID>24498123</PMID>
  </results_reference>
  <results_reference>
    <citation>Pienn M, Kovacs G, Tscherner M, Avian A, Johnson TR, Kullnig P, Stollberger R, Olschewski A, Olschewski H, Bálint Z. Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study. Eur Radiol. 2014 Mar;24(3):668-76. doi: 10.1007/s00330-013-3067-8. Epub 2013 Dec 6.</citation>
    <PMID>24311231</PMID>
  </results_reference>
  <results_reference>
    <citation>Pienn M, Kovacs G, Tscherner M, Johnson TR, Kullnig P, Stollberger R, Olschewski A, Olschewski H, Bálint Z. Determination of cardiac output with dynamic contrast-enhanced computed tomography. Int J Cardiovasc Imaging. 2013 Dec;29(8):1871-8. doi: 10.1007/s10554-013-0279-6. Epub 2013 Aug 23.</citation>
    <PMID>23974909</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>April 13, 2012</study_first_submitted>
  <study_first_submitted_qc>May 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2012</study_first_posted>
  <last_update_submitted>July 12, 2017</last_update_submitted>
  <last_update_submitted_qc>July 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Early diagnosis of pulmonary arterial hypertension</keyword>
  <keyword>dynamic dual-energy computed tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Pulmonary Arterial Hypertension</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

